Blood Products Advisory Committee.
This article was originally published in The Gray Sheet
Executive Summary
Information will be presented March 19 on an emerging infections "plan of action" and FDA will outline its proposal on "plasma inventory hold." The meeting will take place from 8 a.m. to 6 p.m. at the DoubleTree Hotel in Rockville, Maryland. Classification of blood bank software, "relative safety of solvent detergent-treated pooled plasma and single-donor plasma, donor retested," and an FDA proposal on donor deferrals related to xenotransplantation will be discussed on March 20 from 8 a.m. to 3:30 p.m. For more information contact Linda Smallwood at 301/827-3514 or FDA's advisory committee information line at 800/741-8138 and use code 19516...